欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/V/0352/001
药品名称Hipragumboro GM97
活性成分
    • Infectious Bursal Disease (Gumboro) Virus 10.0 EID50/dose
剂型Oral suspension
上市许可持有人Laboratorios Hipra, S.A Avda. La Selva, 135 E-17170 Amer (Girona) Spain
参考成员国 - 产品名称France (FR)
HIPRAGUMBORO-G97
互认成员国 - 产品名称
    • Ireland (IE)
    • Bulgaria (BG)
    • United Kingdom (Northern Ireland) (XI)
      Hipragumboro G97
    • Germany (DE)
      Hipragumboro G97
    • Belgium (BE)
      Hipragumboro-GM97
    • Netherlands (NL)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Hungary (HU)
    • Czechia (CZ)
    • Slovakia (SK)
    • Estonia (EE)
    • Austria (AT)
    • Spain (ES)
    • Latvia (LV)
    • Lithuania (LT)
许可日期2008/04/05
最近更新日期2024/11/18
药物ATC编码
    • QI01AD09 avian infectious bursal disease virus (gumboro disease)
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase